A critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6

Firestein, 2003, Evolving concepts of rheumatoid arthritis, Nature, 423, 356, 10.1038/nature01661 Bottini, 2013, Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors, Nat. Rev. Rheumatol., 9, 24, 10.1038/nrrheum.2012.190 Catrina, 2016, Mechanisms involved in triggering rheumatoid arthritis, Immunol. Rev., 269, 162, 10.1111/imr.12379 McInnes, 2016, Cytokines in rheumatoid arthritis - shaping the immunological landscape, Nat. Rev. Rheumatol., 12, 63, 10.1038/nrrheum.2015.171 Smolen, 2015, Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges, Nat. Rev. Rheumatol., 11, 276, 10.1038/nrrheum.2015.8 Kishimoto, 2010, IL-6: from its discovery to clinical applications, Int. Immunol., 22, 347, 10.1093/intimm/dxq030 Feldmann, 1996, Role of cytokines in rheumatoid arthritis, Annu. Rev. Immunol., 14, 397, 10.1146/annurev.immunol.14.1.397 Dayer, 2010, Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor, Rheumatology, 49, 15, 10.1093/rheumatology/kep329 Laurence, 2007, T(H)-17 differentiation: of mice and men, Nat. Immunol., 8, 903, 10.1038/ni0907-903 Stockinger, 2007, Differentiation and function of Th17 T cells, Curr. Opin. Immunol., 19, 281, 10.1016/j.coi.2007.04.005 Deng, 2010, Yin Yang 1: a multifaceted protein beyond a transcription factor, Transcription, 1, 81, 10.4161/trns.1.2.12375 Zhang, 2011, The oncogenic role of Yin Yang 1, Crit. Rev. Oncog., 16, 163, 10.1615/CritRevOncog.v16.i3-4.30 Seligson, 2005, Expression of transcription factor Yin Yang 1 in prostate cancer, Int. J. Oncol., 27, 131 Begon, 2005, Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells, J. Biol. Chem., 280, 24428, 10.1074/jbc.M503790200 Baritaki, 2009, YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels, Cancer Investig., 27, 184, 10.1080/07357900802210760 Berchuck, 2005, Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res., 11, 3686, 10.1158/1078-0432.CCR-04-2398 Chinnappan, 2009, Transcription factor YY1 expression in human gastrointestinal cancer cells, Int. J. Oncol., 34, 1417 Kang, 2014, Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma, J. Transl. Med., 12, 80, 10.1186/1479-5876-12-80 Sakhinia, 2007, Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling, Blood, 109, 3922, 10.1182/blood-2006-09-046391 Atchison, 2011, Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects, Crit. Rev. Oncog., 16, 143, 10.1615/CritRevOncog.v16.i3-4.20 Aletaha, 2010, 2010 rheumatoid arthritis classification criteria: an American College of rheumatology/European League against rheumatism collaborative initiative, Arthritis Rheum., 62, 2569, 10.1002/art.27584 Altman, 1986, Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the american rheumatism association, Arthritis Rheum., 29, 1039, 10.1002/art.1780290816 Kim, 2002, Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis, Arthritis Rheum., 46, 793, 10.1002/art.10113 Lin, 2012, Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis, J. Immunol., 188, 5776, 10.4049/jimmunol.1103201 Mauri, 2000, Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process, Nat. Med., 6, 673, 10.1038/76251 Lin, 2014, A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis, Arthritis Rheumatol. (Hoboken, NJ), 66, 49, 10.1002/art.38142 Lin, 2016, Datasets of YY1 expression in rheumatoid arthritis patients, Data Brief, 10.1016/j.dib.2016.11.046 Tanaka, 2014, IL-6 in inflammation, immunity, and disease, Cold Spring Harb. Perspect. Biol., 6, a016295, 10.1101/cshperspect.a016295 Smolen, 2008, Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial, Lancet, 371, 987, 10.1016/S0140-6736(08)60453-5 Emery, 2008, IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial, Ann. Rheum. Dis., 67, 1516, 10.1136/ard.2008.092932 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Patel, 2015, Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions, Immunity, 43, 1040, 10.1016/j.immuni.2015.12.003 Kim, 2009, YY1's longer DNA-binding motifs, Genomics, 93, 152, 10.1016/j.ygeno.2008.09.013 Riggs, 1993, Yin-yang 1 activates the c-myc promoter, Mol. Cell. Biol., 13, 7487, 10.1128/MCB.13.12.7487 Natesan, 1993, DNA bending and orientation-dependent function of YY1 in the c-fos promoter, Genes Dev., 7, 2497, 10.1101/gad.7.12b.2497 Wang, 2008, YY1 restrained cell senescence through repressing the transcription of p16, Biochim. Biophys. Acta, 1783, 1876, 10.1016/j.bbamcr.2008.05.015 Ishii, 2012, Yin Yang-1 inhibits tumor cell growth and inhibits p21WAF1/Cip1 complex formation with cdk4 and cyclin D1, Int. J. Oncol., 40, 1575 Austen, 1998, YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc, Oncogene, 17, 511, 10.1038/sj.onc.1201968 Ye, 1996, The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element, Mol. Cell. Biol., 16, 4744, 10.1128/MCB.16.9.4744 Schwenger, 1999, Nuclear factor of activated T cells and YY1 combine to repress IL-5 expression in a human T-cell line, J. Allergy Clin. Immunol., 104, 820, 10.1016/S0091-6749(99)70293-9 Guo, 2001, Yin-Yang 1 activates interleukin-4 gene expression in T cells, J. Biol. Chem., 276, 48871, 10.1074/jbc.M101592200 Keller, 1996, Molecular and cellular biology of interleukin-6 and its receptor, Front. Biosci. J. Virtual Libr., 1, 10.2741/A136 Grassl, 1999, Transcriptional regulation of the interleukin-6 gene in mesangial cells, J. Am. Soc. Nephrol. JASN, 10, 1466, 10.1681/ASN.V1071466 Tanabe, 1988, Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human, J. Immunol., 141, 3875, 10.4049/jimmunol.141.11.3875 Gregoire, 2013, Essential and unexpected role of Yin Yang 1 to promote mesodermal cardiac differentiation, Circ. Res., 112, 900, 10.1161/CIRCRESAHA.113.259259